O-GlcNAc cycling modulates neurodegeneration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 43, 2012, Pages 17319-17320

  Gong, Cheng Xin ^a   Liu, Fei ^a   Iqbal, Khalid ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLGLUCOSAMINE; O LINKED BETA N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG;

CAENORHABDITIS ELEGANS; CATALYSIS; DEGENERATIVE DISEASE; ENZYME METABOLISM; NERVE DEGENERATION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

ACETYLGLUCOSAMINE; ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; HUMANS; MUTATION; NEURODEGENERATIVE DISEASES;

EID: 84867903851     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1215395109     Document Type: Note

References (21)

1. Skovronsky DM, Lee VM, Trojanowski JQ (2006) Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol 1: 151-170.
2. Wang P, et al. (2012) O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases. Proc Natl Acad Sci USA 109:17669-17674.
3. Butkinaree C, Park K, Hart GW (2010) O-linked beta- N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 1800(2):96-106.
4. Love DC, Krause MW, Hanover JA (2010) O-GlcNAc cycling: Emerging roles in development and epigenetics. Semin Cell Dev Biol 21(6):646-654.
5. Liu Y, et al. (2012) Developmental Regulation of Protein O-GlcNAcylation, O-GlcNAc Transferase, and O-GlcNAcase in Mammalian Brain. PLoS ONE 7(8):e43724.
6. Shafi R, et al. (2000) The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA 97(11):5735-5739. (Pubitemid 30367467)
7. Webster DM, et al. (2009) O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development. BMC Dev Biol 9:28.
8. Yuzwa SA, et al. (2008) A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat Chem Biol 4(8):483-490.
9. Liu F, et al. (2009) Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 132(Pt 7):1820-1832.
10. Yuzwa SA, et al. (2012) Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol 8(4):393-399.
11. Liu K, et al. (2004) Accumulation of protein O-GlcNAc modi fication inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism. J Neurochem 89 (4):1044-1055. (Pubitemid 38684749)
12. Alfaro JF, et al. (2012) Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc Natl Acad Sci USA 109(19):7280-7285.
13. Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX (2004) O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA 101(29):10804-10809. (Pubitemid 38955823)
14. Macauley MS, Shan X, Yuzwa SA, Gloster TM, Vocadlo DJ (2010) Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis. Chem Biol 17(9):949- 958.
15. Zachara NE, Hart GW (2004) O-GlcNAc a sensor of cellular state: The role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673 (1-2):13-28. (Pubitemid 38844791)
16. Hanover JA, et al. (2005) A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. Proc Natl Acad Sci USA 102(32):11266- 11271.
17. Li X, Lu F, Wang JZ, Gong CX (2006) Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur J Neurosci 23(8):2078-2086.
18. Gong CX, Grundke-Iqbal I, Iqbal K (2010) Targeting tau protein in Alzheimer ' s disease. Drugs Aging 27 (5):351-365.
19. Griffith LS, Mathes M, Schmitz B (1995) Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine. J Neurosci Res 41(2):270-278.
20. Jacobsen KT, Iverfeldt K (2011) O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP). Biochem Biophys Res Commun 404(3): 882-886.
21. Bertram L, et al. (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290 (5500):2302-2303. (Pubitemid 32041570)